Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2013; 19(8): 1210-1218
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Figure 7
Figure 7 Effects of mitogen-activated protein kinases inhibitors on (±)-S-nitroso-N-acetylpenicillamine-induced action in interstitial cells of Cajal. A: Pacemaker currents of interstitial cells of Cajal (ICCs) treated with 100 μmol/L SNAP at a holding potential of -70 mV; B: Pacemaker currents after pretreatment with PD 98059 (10 μmol/L) prior to SNAP treatment; C: Pacemaker currents after pretreatment with SB 203580 (10 μmol/L) prior to SNAP treatment; D: Pacemaker currents after pretreatment with L-NAME (10 μmol/L) prior to prostaglandin E2 (PGE2) (5 μmol/L) treatment. The effects of mitogen-activated protein kinases inhibitors on the (±)-S-nitroso-N-acetylpenicillamine-induced action are summarized in E and F. Bars represent mean ± SE values (n = 5 per group). Con: Control, PD: PD 98059, SB: SB203580; SNAP: S-nitroso-N-acetylpenicillamine; L-NAME: NG-Nitro-L-arginine Methyl Ester.